Aflac (AFL) Change In Receivables : $-18 Mil (TTM As of Mar. 2025)

View and export this data going back to 1973. Start your Free Trial

What is Aflac Change In Receivables?

Aflac's change in receivables for the quarter that ended in Mar. 2025 was $-37 Mil. It means Aflac's Accounts Receivable increased by $37 Mil from Dec. 2024 to Mar. 2025 .

Aflac's change in receivables for the fiscal year that ended in Dec. 2024 was $51 Mil. It means Aflac's Accounts Receivable declined by $51 Mil from Dec. 2023 to Dec. 2024 .

Aflac's Accounts Receivable for the quarter that ended in Mar. 2025 was $894 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aflac's Days Sales Outstanding for the three months ended in Mar. 2025 was 23.63.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aflac's liquidation value for the three months ended in Mar. 2025 was $-20,842 Mil.

Aflac Change In Receivables Historical Data

The historical data trend for Aflac's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aflac Change In Receivables Chart

Aflac Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

58.00

72.00

5.00

-133.00

51.00

Aflac Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															32.00	-13.00	9.00	23.00	-37.00

Aflac Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18 Mil.

Aflac (NYSE:AFL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aflac's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	894	/	3453	*	91
=	23.63

2. In Ben Graham's calculation of liquidation value, Aflac's accounts receivable are only considered to be worth 75% of book value:

Aflac's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	72408	-	93920	+	0.75 * 894	+	0.5 * 0
=	-20,842

Aflac Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aflac's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Aflac Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Aflac Inc (NYSE:AFL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

1AFL:Italy 0H68:UK AFL:Germany AFL:Germany AFL:Germany AFL:Germany A1FL34:Brazil AFL:Austria

Address

1932 Wynnton Road, Columbus, GA, USA, 31999

Website

https://www.aflac.com

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Executives

Masatoshi Koide	officer: Deputy President, Aflac Japan	1932 WYNNTON RD, COLUMBUS GA 31999
Arthur Reginald Collins	director	3911 LORCOM LANE, ARLINGTON VA 22207
Thomas J Kenny	director	FRANKLIN RESOURCES INC, 901 MARINERS ISLAND BLVD 6TH FLOOR, SAN MATEO CA 94404
Joseph L Moskowitz	director	1932 WYNNTON ROAD, COLUMBUS GA 31999
Lake Charles D Ii	officer: President AFLAC Japan	AFLAC INC, 1932 WYNNTON RD, COLUMBUS GA 31999
Audrey B Tillman	officer: Executive Vice President	1932 WYNNTON RD, COLUMBUS GA 31999
Albert Riggieri	officer: SVP, Corporate Actuary	1932 WYNNTON RD, COLUMBUS GA 31999
Karole Lloyd	director	1932 WYNNTON ROAD, COLUMBUS GA 31999
William P Bowers	director	600 NORTH 18TH STREET, BIN 15N-8170, BIRMINGHAM AL 35203
Barbara K Rimer	director	1932 WYNNTON ROAD, COLUMBUS GA 31999
Steven Kent Beaver	officer: SVP, CFO, Aflac US	1932 WYNNTON ROAD, COLUMBUS GA 31999
June P Howard	officer: Sr. Vice President	1932 WYNNTON RD, COLUMBUS GA 31999
Frederick John Crawford	officer: EVP, Chief Financial Officer	AFLAC INCORPORATED, COLUMBUS GA 31999
Simard Frederic Jean Guy	officer: SVP, CFO, Aflac U.S.	1932 WYNNTON ROAD, COLUMBUS GA 31999
James Todd Daniels	officer: Sr. Vice President	1932 WYNNTON ROAD, COLUMBUS GA 31999